First Patients Enrolled in IMPRoVED-AF Study Using vMap, a Non-Invasive ECG-Based Tool Designed to Guide More Effective AF Ablation
With growing pressure to improve outcomes and reduce re-do procedures, physicians and hospitals are seeking non-invasive tools that can improve targeting while maintaining necessary workflow efficiencies. vMap is designed to address this need...
Share
IMPRoVED-AF is a prospective, randomized, controlled, international, multi-center study designed to rigorously compare clinical outcomes in patients undergoing pulmonary vein isolation (PVI) alone versus PVI and additional driver ablation guided by vMap®, the only FDA-cleared non-invasive arrhythmia analysis technology designed to improve, enhance, and accelerate ablation procedures, utilizing data from a standard 12-lead ECG. The study aims to demonstrate the comparative clinical benefit of using vMap to identify and ablate non-pulmonary vein electrical drivers, when used alongside standard-of-care ablation techniques, including advanced technologies such as pulsed field ablation (PFA), in patients with persistent and recurrent atrial fibrillation (AF).
'Enrolling the first patient in the IMPRoVED-AF study marks an important milestone in our ongoing efforts at Baptist Health to further advance care for our patients suffering from cardiac arrhythmias,' said Dr. Gery Tomassoni, Principal Investigator and cardiac electrophysiologist at Baptist Health Lexington. 'For patients with persistent and recurrent AF, treatment has often been ineffective due to the inability to identify the source of the arrhythmia. Using vMap to determine a targeted ablation strategy beyond the pulmonary veins provides an opportunity to target drivers that were previously undetectable. That means better care and more effective, lasting results for patients.'
With growing pressure to improve outcomes and reduce re-do procedures, physicians and hospitals are seeking non-invasive tools that can improve targeting while maintaining necessary workflow efficiencies. vMap is designed to address this need by delivering rapid analysis and insights from a standard 12-lead ECG.
'The IMPRoVED-AF study is an important validation of the meaningful impact vMap is already delivering in the EP lab,' said Rob Krummen, CEO of Vektor Medical. 'This isn't about incremental improvement; it's a leap forward in how we identify and treat complex arrhythmias. vMap is uncovering drivers that often go undetected, helping physicians deliver more effective and durable outcomes. This study is a critical part of our strategy to build the clinical evidence that drives confident adoption, supports value in health systems, and positions vMap as the new standard in arrhythmia care.'
The IMPRoVED-AF study, managed by Veranex, a global leader in clinical research, will enroll up to 384 patients with persistent and recurrent AF at approximately 20 electrophysiology centers across the United States and Europe. The primary endpoint of the study is freedom from AF at 12 months.
To learn more about the IMPRoVED-AF study, explore vMap technology, or request a clinical or strategic briefing, visit www.vektormedical.com and connect with us on LinkedIn and X.
About vMap®
vMap is the only FDA-cleared, non-invasive solution that transforms data from a standard 12-lead ECG into actionable insights to guide arrhythmia care. The technology, developed with AI, localizes arrhythmia source locations across all four chambers of the heart — including both focal and fibrillation-type arrhythmias. vMap is used by electrophysiologists during triage, procedural planning, and ablation to help identify and target arrhythmia drivers more quickly and with greater confidence. Backed by growing clinical evidence, use of vMap has been associated with improved outcomes, reduced procedure time, and streamlined workflow across the arrhythmia care continuum.
About Vektor Medical
Headquartered in San Diego, Vektor Medical is redefining how arrhythmias are understood and treated. The company developed vMap®, the only FDA-cleared, non-invasive technology that uses standard 12-lead ECG data to localize arrhythmia source locations across all four chambers of the heart. By helping physicians identify arrhythmia drivers more quickly and with greater accuracy, Vektor is working to improve outcomes, enhance efficiencies, and accelerate access to effective treatment strategies. To learn more, visit www.vektormedical.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Ousted FDA vaccine chief Vinay Prasad is returning to the agency
WASHINGTON (AP) — A Food and Drug Administration official is getting his job back as the agency's top vaccine regulator, less than two weeks after he was pressured to step down at the urging of biotech executives, patient groups and conservative allies of President Donald Trump. Dr. Vinay Prasad is resuming leadership of the FDA center that regulates vaccines and biotech therapies, a spokesperson for the Department of Health and Human Services said in a statement Monday. Prasad left the agency late last month after drawing ire of right-wing activists, including Laura Loomer, because of his past statements criticizing Trump. A longtime a critic of FDA's standards for approving medicines, Prasad briefly ordered the maker of a gene therapy for Duchenne's muscular dystrophy to halt shipments after two patient deaths. But that action triggered pushback from the families of boys with the fatal condition and libertarian supporters of increased access to experimental medicines. Prasad's decision to pause the therapy was criticized by The Wall Street Journal editorial board, former Republican Sen. Rick Santorum and others. The FDA swiftly reversed its decision suspending the therapy's use. Loomer posted online that Prasad was 'a progressive leftist saboteur,' noting his history of praising liberal independent Sen. Bernie Sanders. But Prasad has had the backing of FDA Commissioner Marty Makary and health secretary Robert F. Kennedy Jr., who have both called for scrutinizing the use of COVID-19 vaccines. Under Prasad, the FDA restricted the approval of two new COVID-19 shots from vaccine makers Novavax and Moderna and set stricter testing requirements for future approvals. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. The Associated Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
3 minutes ago
- Business Wire
Science Fair Foundation of BC opens registration for Youth Innovation Showcase
VANCOUVER, British Columbia--(BUSINESS WIRE)--The Science Fair Foundation of BC (SFFBC) is excited to announce that registration is now open for the Youth Innovation Showcase (YIS), a virtual STEM competition with all-new dates. Youth across British Columbia and Yukon are invited to showcase their creativity and problem-solving skills by sharing science-based solutions to challenges in their life or community. Going into its seventh year, the Youth Innovation Showcase brings together passion, ingenuity and scientific creativity. Young people are constantly ideating how to solve some of the world's problems, and SFFBC aims to help illustrate that the youth of today will be the leaders of tomorrow's science and technology sector. Youth across British Columbia and Yukon are invited to showcase their creativity and problem-solving skills by sharing science-based solutions to challenges in their life or community. Share Whether a project is fully developed or just an idea, participants can compete individually or in teams of up to two people, and will be divided into two age categories: 12 to 15 years old and 16 to 19 years old, with each offering a $5,000 grand prize. Projects must be innovative and unique, as previous winning entries are not eligible for entry. For inspiration, participants can explore inspiration from past finalists and semi-finalists. "The Youth Innovation Showcase is back for its seventh year, and we couldn't be more excited to showcase the talent," said Sarah Prade, Executive Director of the Science Fair Foundation of BC. "Last year's applicants were truly inspiring, and we look forward to seeing the innovative ideas and unique skills this year's participants will bring to the table." The showcase has sponsorship and judging support from prominent organizations in BC's technology community, as well as returning alumni with a refreshed evaluation criteria. This year also marks the second edition of the YIS Visionary Award, celebrating young individuals who demonstrate entrepreneurial passion and excel in communication. Participants will showcase their ideas through compelling presentation materials, including a one-page report and a pitch video. The award will honour youth who are forward-thinking visionaries, identifying the future needs of their family, community, or society, and articulating how their innovation addresses those needs. Finalists will attend the Awards Show on January 28, 2026, where the grand prize winners will be announced and receive feedback from judges. The Awards Show has been pushed later this year to give students ample time over the winter break to prepare their Finalist submissions and get ready for their interviews. Please see below for the full list of key dates. For details on how to register, visit for more information and details on the YIS 2025 Workshop Series to help students get started. Important Dates Registration Opens – August 11, 2025 Registration Deadline – September 29, 2025 Semi-Finalists Announced – October 22, 2025 Semi-Finalist Interviews – November 18, 2025 Finalists Announced – December 1, 2025 Finalist Interviews – January 13, 2026 Awards Show – January 28, 2026 About Science Fair Foundation of BC The Science Fair Foundation of BC (SFFBC) is the largest volunteer science outreach network in the province, dedicated to fostering science and technology education by inspiring curiosity through the Science Fair program. Established in 1997, SFFBC supports Science Fairs across British Columbia and the Yukon by uniting over 1,500 educators, industry professionals, and volunteers as mentors, judges, and hosts. This collaboration empowers students to excel at regional, national, and international competitions, where Team BC has consistently achieved outstanding results. With 13 regional fairs in BC contributing to over 100 held annually across Canada, SFFBC plays a vital role in preparing the next generation for success in a knowledge-based economy.
Associated Press
4 minutes ago
- Associated Press
Ousted FDA vaccine chief Vinay Prasad is returning to the agency
WASHINGTON (AP) — A Food and Drug Administration official is getting his job back as the agency's top vaccine regulator, less than two weeks after he was pressured to step down at the urging of biotech executives, patient groups and conservative allies of President Donald Trump. Dr. Vinay Prasad is resuming leadership of the FDA center that regulates vaccines and biotech therapies, a spokesperson for the Department of Health and Human Services said in a statement Monday. Prasad left the agency late last month after drawing ire of right-wing activists, including Laura Loomer, because of his past statements criticizing Trump. A longtime a critic of FDA's standards for approving medicines, Prasad briefly ordered the maker of a gene therapy for Duchenne's muscular dystrophy to halt shipments after two patient deaths. But that action triggered pushback from the families of boys with the fatal condition and libertarian supporters of increased access to experimental medicines. Prasad's decision to pause the therapy was criticized by The Wall Street Journal editorial board, former Republican Sen. Rick Santorum and others. The FDA swiftly reversed its decision suspending the therapy's use. Loomer posted online that Prasad was 'a progressive leftist saboteur,' noting his history of praising liberal independent Sen. Bernie Sanders. But Prasad has had the backing of FDA Commissioner Marty Makary and health secretary Robert F. Kennedy Jr., who have both called for scrutinizing the use of COVID-19 vaccines. Under Prasad, the FDA restricted the approval of two new COVID-19 shots from vaccine makers Novavax and Moderna and set stricter testing requirements for future approvals. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
